Standard Family Office’s Thermo Fisher Scientific TMO Stock Holding History

Standard Family Office’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$70.8K	Hold	144	–	–	0.07%	21
2025 Q4	$83.4K	Hold	144	–	–	0.09%	18
2025 Q3	$69.8K	Hold	144	–	–	0.08%	22
2025 Q2	$58.4K	Hold	144	–	–	0.07%	23
2025 Q1	$71.7K	Sell	144 -111	-44%	-$60.1K	0.09%	19
2024 Q4	$133K	Hold	255	–	–	0.16%	18
2024 Q3	$158K	Hold	255	–	–	0.19%	16
2024 Q2	$141K	Hold	255	–	–	0.18%	16
2024 Q1	$148K	Buy	+255	New	+$143K	0.2%	16
2022 Q4	–	Sell	-40	Closed	-$20K	–	402
2022 Q3	$20K	Buy	+40	New	+$22.4K	0.01%	205
2021 Q4	–	Sell	-200	Closed	-$114K	–	241
2021 Q3	$114K	Sell	200 -1,814	-90%	-$996K	0.03%	17
2021 Q2	$1.02M	Buy	2,014 +200	+11%	+$94.4K	0.21%	43
2021 Q1	$828K	Sell	1,814 -200	-10%	-$95.5K	0.2%	42
2020 Q4	$938K	Buy	+2,014	New	+$944K	0.22%	35

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Standard Family Office's TMO Position: Q1 2026 in Review

Standard Family Office held its Thermo Fisher Scientific (TMO) position steady in Q1 2026 at 144 shares worth $70.8K. The position accounts for 0.07% of the portfolio, ranked #21.

Standard Family Office first reported a position in TMO in Q4 2020 and has held it in 14 quarters since. The position peaked at $1.02M in Q2 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Standard Family Office held 144 shares of Thermo Fisher Scientific worth $70.8K as of Q1 2026.
Standard Family Office left its Thermo Fisher Scientific share count unchanged in Q1 2026.
Thermo Fisher Scientific made up 0.07% of Standard Family Office's portfolio in Q1 2026, its #21 holding.
Standard Family Office first reported a position in Thermo Fisher Scientific in Q4 2020 and has held it in 14 quarters since.
Standard Family Office's Thermo Fisher Scientific position peaked at $1.02M in Q2 2021.
2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Standard Family Office's 13F filing for Q1 2026, filed 14 May 2026.